Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 23, 2017

DrugPatentWatch Database Preview

Calcium acetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for calcium acetate and what is the scope of patent protection?

Calcium acetate
is the generic ingredient in five branded drugs marketed by Cypress Pharm, Chartwell Rx, Heritage Pharms Inc, Invagen Pharms, Lupin Ltd, West-ward Pharms Int, Amneal Pharms, Fresenius Medcl, Paddock Llc, Nostrum Labs Inc, and Eci Pharms Llc, and is included in sixteen NDAs. There are six patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Calcium acetate has twenty-two patent family members in seventeen countries.

There are two hundred and sixty-two drug master file entries for calcium acetate. Thirty suppliers are listed for this compound.

Summary for Generic Name: calcium acetate

Drug Master File Entries: see list262
Suppliers / Packagers: see list30
Bulk Api Vendors: see list28
Clinical Trials: see list1,152
Therapeutic Class:Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:calcium acetate at DailyMed

Pharmacology for Ingredient: calcium acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Medcl
calcium acetate
CAPSULE;ORAL021160-001Apr 2, 2001DISCNNoNo► Subscribe► Subscribe
Fresenius Medcl
calcium acetate
TABLET;ORAL019976-001Dec 10, 1990DISCNYesNo► Subscribe► Subscribe
Cypress Pharm
calcium acetate
TABLET;ORAL078502-001Nov 25, 2008ABRXNoYes► Subscribe► Subscribe
Lupin Ltd
calcium acetate
CAPSULE;ORAL202127-001Jul 9, 2015ABRXNoNo► Subscribe► Subscribe
Fresenius Medcl
calcium acetate
CAPSULE;ORAL021160-003Apr 2, 2001ABRXYesYes6,576,665► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus